Signaling and apoptosis differences between severe hypoxia and desferoxamine treatment of human epithelial cells.
D017209:Apoptosis / Q000502:physiology*; D002460:Cell Line; D003676:Deferoxamine / Q000494:pharmacology*; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D000860:Hypoxia / Q000378:metabolism*; D011480:Protease Inhibitors / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D017262:Siderophores / Q000494:pharmacology*; D015398:Signal Transduction / Q000502:physiology*
D011480:Protease Inhibitors; D017262:Siderophores; D000071679:Glycogen Synthase Kinase 3 beta; D051057:Proto-Oncogene Proteins c-akt; D038362:Glycogen Synthase Kinase 3; D003676:Deferoxamine